Table 1.
Roles of Human cytomegalovirus (HCMV) microRNAs (miRNAs) in latency and reactivation. List of HCMV-encoded miRNAs are shown along with their roles in latency and reactivation, or other roles not yet tested in cells that support latent infection.
miRNA | Role in Latency/Reactivation | Other Roles |
---|---|---|
miR-US4-5p | Unknown | |
miR-US4-3p | Unknown | Targets CASP7, may affect apoptosis signaling [74] |
miR-US5-1 | Inhibits apoptosis during latency establishment via FOXO3a downregulation [77] | Targets HCMV US7 [68] |
Inhibits production of IL-6 and RANTES through IKKα and IKKβ targeting [100] | ||
Restructures the endocytic recycling compartment to limit cytokine secretion [102] | ||
Targets FADD, may affect apoptosis signaling [74] | ||
miR-US5-2 | Promotes TGFβ secretion by targeting the transcriptional repressor NAB1, mediates myelosuppression [16] | Targets HCMV US7 [68] |
Targets GAB1 to indirectly regulation EGR-1 and HCMV UL138 expression [99] | ||
Restructures the endocytic recycling compartment to limit cytokine secretion [102] | ||
Targets FAS, may affect apoptosis signaling [74] | ||
miR-UL22A-5p | Targets SMAD3 to limit TGFβ signaling and maintain viral genomes during latency [16] | |
miR-UL22A-3p | Targets SMAD3 to limit TGFβ signaling and maintain viral genomes during latency [16] | Targets CASP7, may affect apoptosis signaling [74] |
miR-US22 | Disrupts EGFR-UL138 signaling loop by targeting EGR-1 to induce viral reactivation [14] | |
Inhibits CD34+ HPC proliferation by targeting EGR-1 [15] | ||
miR-US25-1 | Targets RhoA to limit proliferation and maintain viral genomes during latency [88] | |
miR-US25-2-5p | Unknown | |
miR-US25-2-3p | Unknown | Targets CASP3, may affect apoptosis signaling [74] |
miR-US29 | Unknown | |
miR-US33 | Unknown | |
miR-UL36 | Unknown | Targets HCMV UL138 [69] |
miR-UL36-5p | Unknown | Targets SCL25A6/ANT3, inhibits apoptosis [75] |
miR-UL36-3p | Unknown | Targets FAS, may affect apoptosis signaling [74] |
miR-UL112-3p | Inhibits apoptosis during latency establishment via FOXO3a downregulation [77] | Inhibits production of IL-6 and RANTES through IKKα and IKKβ targeting [100] |
Targets HCMV IE72 to limit IE gene expression and CTL recognition [67] | Targets HCMV UL112/113 and UL120/121 [65] | |
Limits NK cell-mediated cytotoxicity through MICB targeting [103] | ||
Restructures the endocytic recycling compartment to limit cytokine secretion [102] | ||
miR-UL148D | Promotes latency establishment by indirectly inhibiting IE gene expression via IER5 downregulation [51] | Targets RANTES [101] |
Targets ACVR1B to limit proinflammatory cytokine levels [50] | Targets IEX1, inhibits apoptosis [76] |